Jiao Y - Search Results

1

Cysteine conjugate beta-lyase 2 (CCBL2) expression as a prognostic marker of survival in breast cancer patients.

Meng X, Wang L, He M, Yang Z, Jiao Y, Hu Y, Wang K. Meng X, et al. Among authors: jiao y. PLoS One. 2022 Jun 30;17(6):e0269998. doi: 10.1371/journal.pone.0269998. eCollection 2022. PLoS One. 2022. PMID: 35771747 Free PMC article.

2

Aberrant FAM64A mRNA expression is an independent predictor of poor survival in pancreatic cancer.

Jiao Y, Fu Z, Li Y, Zhang W, Liu Y. Jiao Y, et al. PLoS One. 2019 Jan 29;14(1):e0211291. doi: 10.1371/journal.pone.0211291. eCollection 2019. PLoS One. 2019. PMID: 30695070 Free PMC article.

3

Low CYP24A1 mRNA expression and its role in prognosis of breast cancer.

Cai H, Jiao Y, Li Y, Yang Z, He M, Liu Y. Cai H, et al. Among authors: jiao y. Sci Rep. 2019 Sep 23;9(1):13714. doi: 10.1038/s41598-019-50214-z. Sci Rep. 2019. PMID: 31548577 Free PMC article.

4

A new prognostic factor of breast cancer: High carboxyl ester lipase expression related to poor survival.

Cui Y, Jiao Y, Wang K, He M, Yang Z. Cui Y, et al. Among authors: jiao y. Cancer Genet. 2019 Nov;239:54-61. doi: 10.1016/j.cancergen.2019.09.005. Epub 2019 Sep 18. Cancer Genet. 2019. PMID: 31561066 Free article.

5

High peroxidasin-like expression is a potential and independent prognostic biomarker in breast cancer.

Li Y, Jiao Y, Luo Z, Li Y, Liu Y. Li Y, et al. Among authors: jiao y. Medicine (Baltimore). 2019 Nov;98(44):e17703. doi: 10.1097/MD.0000000000017703. Medicine (Baltimore). 2019. PMID: 31689799 Free PMC article.

6

OGDHL Expression as a Prognostic Biomarker for Liver Cancer Patients.

Jiao Y, Li Y, Fu Z, Hou L, Chen Q, Cai Y, Jiang P, He M, Yang Z. Jiao Y, et al. Dis Markers. 2019 Oct 17;2019:9037131. doi: 10.1155/2019/9037131. eCollection 2019. Dis Markers. 2019. PMID: 31781311 Free PMC article.

7

Elevated high mobility group A2 expression in liver cancer predicts poor patient survival.

Zhao YC, Jiao Y, Li YQ, Fu Z, Yang ZY, He M. Zhao YC, et al. Among authors: jiao y. Rev Esp Enferm Dig. 2020 Jan;112(1):27-33. doi: 10.17235/reed.2019.6365/2019. Rev Esp Enferm Dig. 2020. PMID: 31823639 Free article.

8

Low EIF2B5 expression predicts poor prognosis in ovarian cancer.

Hou L, Jiao Y, Li Y, Luo Z, Zhang X, Pan G, Zhao Y, Yang Z, He M. Hou L, et al. Among authors: jiao y. Medicine (Baltimore). 2020 Jan;99(5):e18666. doi: 10.1097/MD.0000000000018666. Medicine (Baltimore). 2020. PMID: 32000373 Free PMC article.

9

Rab22a is a novel prognostic marker for cell progression in breast cancer.

He M, Shen L, Jiang C, Gao G, Wang K, Jiao Y, Sun L, Cui Y, Ke Z, Yang Z. He M, et al. Among authors: jiao y. Int J Mol Med. 2020 Apr;45(4):1037-1046. doi: 10.3892/ijmm.2020.4486. Epub 2020 Feb 5. Int J Mol Med. 2020. PMID: 32124943 Free PMC article. Clinical Trial.

10

The Prediction and Prognostic Significance of INPP5K Expression in Patients with Liver Cancer.

Wang R, Jiao Y, Li Y, Ye S, Pan G, Qin S, Hua F, Liu Y. Wang R, et al. Among authors: jiao y. Biomed Res Int. 2020 Apr 25;2020:9519235. doi: 10.1155/2020/9519235. eCollection 2020. Biomed Res Int. 2020. PMID: 32420386 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,952 results

Search Page